» Articles » PMID: 27843749

Mortality Markers in Nosocomial Bloodstream Infection

Overview
Journal Springerplus
Date 2016 Nov 16
PMID 27843749
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: is the most common endogen agent for nosocomial infections. In this study, mortality markers were investigated in patients with nosocomial blood stream infection (NKp BSI).

Methods: The characteristics of patients >16 years who had NKp BSI diagnosis by daily active surveillance between January 2012 and January 2016 were retrospectively evaluated. Patients who died until 28th day of the clinical follow up and those who survived until this time were statistically compared in terms of various risk factors.

Results: One hundred ninety patients were included into the study. Mortality rate was 47.9%, carbapenem resistance was 43.2%. Statistical analysis have shown that in presence of post-NKp BSI sepsis, septic shock, following in intensive care unit (ICU), meropenem resistance, kidney failure, NKp BSI secondary to pneumonia, use of invasive instruments such as central venous catheter (CVC), urinary catheter (UC) and mechanical ventilator (MV), colostomy, transfusion and hemodialysis mortality was significantly higher. In patients admitted into the hospital for neurological disorders, pancreaticobiliary tract (PBT) diseases and patients who have undergone endoscopic retrograde cholangiopancreatography (ERCP) and patients in whom NKp BSI secondary to PBT infection mortality rate was lower.

Conclusions: Sepsis, septic shock, clinical conditions requiring ICU treatment and meropenem resistance increase mortality rates in NKp BSI significantly. Mortality was higher also in patients with NKp BSI secondary to pneumonia, in kidney failure and when invasive instruments were used. On the other hand, in patients who were admitted to the hospital for neurological disorders and PBT diseases mortality rate was lower.

Citing Articles

Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis.

Mathu R, Diago-Navarro E, Lynch E, Degail M, Ousley J, Kanapathipillai R JAC Antimicrob Resist. 2025; 7(1):dlaf010.

PMID: 39973906 PMC: 11836886. DOI: 10.1093/jacamr/dlaf010.


Relationship between virulence and carbapenem resistance phenotype of from blood infection: identification of a carbapenem-resistant and hypervirulent strain.

Liao Q, Zhang W, Deng J, Wu S, Liu Y, Xiao Y Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(4):490-497.

PMID: 39183061 PMC: 11375489. DOI: 10.3724/zdxbyxb-2024-0104.


Antimicrobial activity of phenyllactic acid against Klebsiella pneumoniae and its effect on cell wall membrane and genomic DNA.

Yu J, Hong C, Yin L, Ping Q, Hu G Braz J Microbiol. 2023; 54(4):3245-3255.

PMID: 37728681 PMC: 10689709. DOI: 10.1007/s42770-023-01126-8.


Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet Neurol. 2023; 22(8):685-711.

PMID: 37479374 PMC: 10356620. DOI: 10.1016/S1474-4422(23)00195-3.


The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis.

Allel K, Stone J, Undurraga E, Day L, Moore C, Lin L PLoS Med. 2023; 20(6):e1004199.

PMID: 37347726 PMC: 10287017. DOI: 10.1371/journal.pmed.1004199.


References
1.
Kaiser R, Castanheira M, Jones R, Tenover F, Lynfield R . Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 2013; 76(3):356-60. DOI: 10.1016/j.diagmicrobio.2013.03.032. View

2.
van Duin D, Perez F, Rudin S, Cober E, Hanrahan J, Ziegler J . Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother. 2014; 58(7):4035-41. PMC: 4068524. DOI: 10.1128/AAC.02636-14. View

3.
Pau C, Ma F, Ip M, You J . Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong. Infect Dis (Lond). 2015; 47(5):283-8. DOI: 10.3109/00365548.2014.985710. View

4.
Budak S, Oncul O, Aktas Z, Acar A, Ozyurt M, Turhan V . The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors. Southeast Asian J Trop Med Public Health. 2014; 45(1):113-22. View

5.
Michalopoulos A, Falagas M, Karatza D, Alexandropoulou P, Papadakis E, Gregorakos L . Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control. 2010; 39(5):396-400. DOI: 10.1016/j.ajic.2010.06.017. View